News

Moderna Earnings: What To Look For From MRNA

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Editas Medicine: Primed For An Unlikely Comeback? It's Not Impossible

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

SMX Is Opening the Sustainability Market for GenX and Millennial Investors

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / For decades, sustainability markets operated like closed clubs-built by ...

Stop the Corporate Rhetoric – SMX Makes Decarbonization Measurable, Not Marketing

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / Europe is reaching a pivotal moment in its industrial transformation. And ...

Highlander Silver Reports First Drill Results from Bonita Open Pit Target, Including High Grades over Broad Widths from Near Surface in Every Hole

TORONTO, ON / ACCESS Newswire / July 29, 2025 / Highlander Silver Corp. (TSX:HSLV) (“Highlander Silver” or the “Company“) is ...

XBI: Surprise Exit Of A Tough Regulator At The FDA

The SPDR® S&P Biotech ETF rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a ...

Amarin: Q2 Earnings Snapshot

Amarin Corp. PLC (AMRN) on Wednesday reported a second-quarter loss of $14.1 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Dublin-based company said it ...